Categories AlphaGraphs, Earnings, Health Care

Infographic: Highlights of Merck & Co. (MRK)Q4 2020 earnings report

Merck & Co., Inc. (NYSE: MRK) reported weak earnings and sales for the fourth quarter of 2020.

Worldwide sales edged up 5% year-over-year to $12.5 billion but failed to match the expectations.

Net loss for the quarter was $2.09 billion or $0.83 per share compared to a profit of $2.35 billion or $0.92 per share last year.

The adjusted EPS increased by 17% to $1.32 per share.

  • Merck (MRK) Q2 2020 Earnngs Infograph
  • Merck & Co. announces financial results for first quarter 2020

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top